{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:05:12Z","timestamp":1766901912409,"version":"3.48.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11073-2","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:12:14Z","timestamp":1760004734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Altered miR-203a and miR-3622b-5p expressions in multiple sclerosis: novel correlations with apoptotic gene expression profiles"],"prefix":"10.1007","volume":"52","author":[{"given":"Arezoo","family":"Azarian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0108-5275","authenticated-orcid":false,"given":"Samaneh Reiszadeh","family":"Jahromi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiana","family":"Bahramzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-3775","authenticated-orcid":false,"given":"Kolsoum","family":"Saeidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoda","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"8","key":"11073_CR1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1177\/1352458517694432","volume":"23","author":"G Kobelt","year":"2017","unstructured":"Kobelt G, Thompson A, Berg J et al (2017) New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler 23(8):1123\u20131136. https:\/\/doi.org\/10.1177\/1352458517694432","journal-title":"Mult Scler"},{"issue":"1","key":"11073_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis - a review. Eur J Neurol 26(1):27\u201340. https:\/\/doi.org\/10.1111\/ene.13819","journal-title":"Eur J Neurol"},{"issue":"1\u20132","key":"11073_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2014.12.020","volume":"160","author":"P Brodin","year":"2015","unstructured":"Brodin P, Jojic V, Gao T et al (2015) Variation in the human immune system is largely driven by non-heritable influences. Cell 160(1\u20132):37\u201347. https:\/\/doi.org\/10.1016\/j.cell.2014.12.020","journal-title":"Cell"},{"issue":"7","key":"11073_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","volume":"9","author":"SV Ramagopalan","year":"2010","unstructured":"Ramagopalan SV, Dobson R, Meier UC, Giovannoni G (2010) Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 9(7):727\u2013739. https:\/\/doi.org\/10.1016\/S1474-4422(10)70094-6","journal-title":"Lancet Neurol"},{"issue":"12","key":"11073_CR5","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1080\/14737175.2021.1978843","volume":"21","author":"A Zarghami","year":"2021","unstructured":"Zarghami A, Li Y, Claflin SB, van der Mei I, Taylor BV (2021) Role of environmental factors in multiple sclerosis. Expert Rev Neurother 21(12):1389\u20131408. https:\/\/doi.org\/10.1080\/14737175.2021.1978843","journal-title":"Expert Rev Neurother"},{"key":"11073_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/B978-0-444-52001-2.00014-5","volume":"122","author":"C Confavreux","year":"2014","unstructured":"Confavreux C, Vukusic S (2014) The clinical course of multiple sclerosis. Handb Clin Neurol 122:343\u2013369. https:\/\/doi.org\/10.1016\/B978-0-444-52001-2.00014-5","journal-title":"Handb Clin Neurol"},{"key":"11073_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"issue":"1","key":"11073_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan SS, Lieberman PM (2023) Epstein-Barr virus and multiple sclerosis. Nat Rev Microbiol 21(1):51\u201364. https:\/\/doi.org\/10.1038\/s41579-022-00770-5","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"11073_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028928","volume":"8","author":"S Klineova","year":"2018","unstructured":"Klineova S, Lublin FD (2018) Clinical course of multiple sclerosis. Cold Spring Harb Perspect Med 8(9):a028928. https:\/\/doi.org\/10.1101\/cshperspect.a028928","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"11073_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s40265-022-01672-9","volume":"82","author":"YN Lamb","year":"2022","unstructured":"Lamb YN, Ocrelizumab (2022) A review in multiple sclerosis. Drugs 82(3):323\u2013334. https:\/\/doi.org\/10.1007\/s40265-022-01672-9","journal-title":"Drugs"},{"key":"11073_CR11","doi-asserted-by":"publisher","unstructured":"Lublin FD, Coetzee T, Cohen JA, Marrie RA, Thompson AJ, International Advisory Committee on Clinical Trials in MS (2022). The 2013 clinical course descriptors for multiple sclerosis: A clarification [published correction appears in Neurology. ;98(5):215. https:\/\/doi.org\/10.1212\/WNL.0000000000011198.]. Neurology. 2020;94(24):1088\u20131092. doi:10.1212\/WNL.0000000000009636","DOI":"10.1212\/WNL.0000000000011198.]"},{"key":"11073_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","volume":"17","author":"S Rodr\u00edguez Mur\u00faa","year":"2022","unstructured":"Rodr\u00edguez Mur\u00faa S, Farez MF, Quintana FJ (2022) The immune response in multiple sclerosis. Annu Rev Pathol 17:121\u2013139. https:\/\/doi.org\/10.1146\/annurev-pathol-052920-040318","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"11073_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7010014","volume":"7","author":"J Correale","year":"2019","unstructured":"Correale J, Marrodan M, Ysrraelit MC (2019) Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis. Biomedicines 7(1):14. https:\/\/doi.org\/10.3390\/biomedicines7010014","journal-title":"Biomedicines"},{"issue":"1","key":"11073_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.expneurol.2009.10.009","volume":"225","author":"H Lassmann","year":"2010","unstructured":"Lassmann H (2010) Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models. Exp Neurol 225(1):2\u20138. https:\/\/doi.org\/10.1016\/j.expneurol.2009.10.009","journal-title":"Exp Neurol"},{"issue":"9107","key":"11073_CR15","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0140-6736(05)60642-3","volume":"351","author":"MP Pender","year":"1998","unstructured":"Pender MP (1998) Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis. Lancet 351(9107):978\u2013981. https:\/\/doi.org\/10.1016\/S0140-6736(05)60642-3","journal-title":"Lancet"},{"key":"11073_CR16","doi-asserted-by":"publisher","first-page":"996469","DOI":"10.3389\/fimmu.2022.996469","volume":"13","author":"R Liu","year":"2022","unstructured":"Liu R, Du S, Zhao L et al (2022) Autoreactive lymphocytes in multiple sclerosis: pathogenesis and treatment target. Front Immunol 13:996469 Published 2022 Sep 23. https:\/\/doi.org\/10.3389\/fimmu.2022.996469","journal-title":"Front Immunol"},{"issue":"4","key":"11073_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.semcancer.2004.04.002","volume":"14","author":"B Nachmias","year":"2004","unstructured":"Nachmias B, Ashhab Y, Ben-Yehuda D (2004) The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol 14(4):231\u2013243. https:\/\/doi.org\/10.1016\/j.semcancer.2004.04.002","journal-title":"Semin Cancer Biol"},{"key":"11073_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.csbj.2019.01.009","volume":"17","author":"F Cossu","year":"2019","unstructured":"Cossu F, Milani M, Mastrangelo E, Lecis D (2019) Targeting the BIR domains of inhibitor of apoptosis (IAP) proteins in cancer treatment. Comput Struct Biotechnol J 17:142\u2013150. https:\/\/doi.org\/10.1016\/j.csbj.2019.01.009","journal-title":"Comput Struct Biotechnol J"},{"issue":"11","key":"11073_CR19","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1080\/14712598.2021.1918672","volume":"21","author":"Y Li","year":"2021","unstructured":"Li Y, Lu W, Yang J, Edwards M, Jiang S (2021) Survivin as a biological biomarker for diagnosis and therapy. Expert Opin Biol Ther 21(11):1429\u20131441. https:\/\/doi.org\/10.1080\/14712598.2021.1918672","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"11073_CR20","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/molecules28031376","volume":"28","author":"N Albadari","year":"2023","unstructured":"Albadari N, Li W (2023) Survivin small molecules inhibitors: recent advances and challenges. Molecules 28(3):1376 Published 2023 Feb 1. https:\/\/doi.org\/10.3390\/molecules28031376","journal-title":"Molecules"},{"issue":"7","key":"11073_CR21","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.223826","volume":"132","author":"SP Wheatley","year":"2019","unstructured":"Wheatley SP, Altieri DC (2019) Survivin at a glance. J Cell Sci 132(7):jcs223826. https:\/\/doi.org\/10.1242\/jcs.223826","journal-title":"J Cell Sci"},{"issue":"9","key":"11073_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/gtmb.2021.0286","volume":"26","author":"MA Mart\u00ednez-Sifuentes","year":"2022","unstructured":"Mart\u00ednez-Sifuentes MA, Bassol-Mayagoitia S, Nava-Hern\u00e1ndez MP et al (2022) Survivin in breast cancer: a review. Genet Test Mol Biomarkers 26(9):411\u2013421. https:\/\/doi.org\/10.1089\/gtmb.2021.0286","journal-title":"Genet Test Mol Biomarkers"},{"key":"11073_CR23","doi-asserted-by":"publisher","unstructured":"Shomali N, Suliman Maashi M, Baradaran B et al (2023) Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies [retracted in: Front Immunol. ; 14:1285591]. Front Immunol. 2022; 13:839945. Published 2022 Mar 3. https:\/\/doi.org\/10.3389\/fimmu.2022.839945","DOI":"10.3389\/fimmu.2022.839945"},{"issue":"4","key":"11073_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.humimm.2023.01.009","volume":"84","author":"A Jafarzadeh","year":"2023","unstructured":"Jafarzadeh A, Bazargan N, Chatrabnous N, Jafarzadeh S, Nemati M (2023) Contribution of survivin to the immune system, allergies and autoimmune diseases. Hum Immunol 84(4):301\u2013310. https:\/\/doi.org\/10.1016\/j.humimm.2023.01.009","journal-title":"Hum Immunol"},{"issue":"2","key":"11073_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/s0165-5728(01)00389-7","volume":"119","author":"MK Sharief","year":"2001","unstructured":"Sharief MK, Semra YK (2001) Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis. J Neuroimmunol 119(2):358\u2013364. https:\/\/doi.org\/10.1016\/s0165-5728(01)00389-7","journal-title":"J Neuroimmunol"},{"issue":"11","key":"11073_CR26","doi-asserted-by":"publisher","first-page":"19440","DOI":"10.1002\/jcp.28725","volume":"234","author":"Y Pahlavan","year":"2019","unstructured":"Pahlavan Y, Kahroba H, Samadi N, Karimi A, Ansarin K, Khabbazi A (2019) Survivin modulatory role in autoimmune and autoinflammatory diseases. J Cell Physiol 234(11):19440\u201319450. https:\/\/doi.org\/10.1002\/jcp.28725","journal-title":"J Cell Physiol"},{"key":"11073_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122788","volume":"350","author":"G Siragusa","year":"2024","unstructured":"Siragusa G, Tomasello L, Giordano C, Pizzolanti G (2024) Survivin (BIRC5): implications in cancer therapy. Life Sci 350:122788. https:\/\/doi.org\/10.1016\/j.lfs.2024.122788","journal-title":"Life Sci"},{"issue":"5","key":"11073_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052589","volume":"25","author":"C Grunwald","year":"2024","unstructured":"Grunwald C, Kr\u0119towska-Grunwald A, Adamska-Patruno E, Kochanowicz J, Ku\u0142akowska A, Chor\u0105\u017cy M (2024) The role of selected interleukins in the development and progression of multiple sclerosis-a systematic review. Int J Mol Sci 25(5):2589. https:\/\/doi.org\/10.3390\/ijms25052589","journal-title":"Int J Mol Sci"},{"issue":"5","key":"11073_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/15321819.2019.1655649","volume":"40","author":"S Tahani","year":"2019","unstructured":"Tahani S, Dehghani L, Jahanbani-Ardakani H (2019) Elevated serum level of IL-4 in neuromyelitis Optica and multiple sclerosis patients. J Immunoassay Immunochem 40(5):555\u2013563. https:\/\/doi.org\/10.1080\/15321819.2019.1655649","journal-title":"J Immunoassay Immunochem"},{"issue":"5","key":"11073_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/08820139.2018.1425699","volume":"47","author":"XX Wang","year":"2018","unstructured":"Wang XX, Chen T (2018) Meta-analysis of the association of IL2RA polymorphisms rs2104286 and rs12722489 with multiple sclerosis risk. Immunol Invest 47(5):431\u2013442. https:\/\/doi.org\/10.1080\/08820139.2018.1425699","journal-title":"Immunol Invest"},{"issue":"6","key":"11073_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00702-004-0225-9","volume":"112","author":"H Bartosik-Psujek","year":"2005","unstructured":"Bartosik-Psujek H, Stelmasiak Z (2005) Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients. J Neural Transm (Vienna) 112(6):797\u2013803. https:\/\/doi.org\/10.1007\/s00702-004-0225-9","journal-title":"J Neural Transm (Vienna)"},{"issue":"24","key":"11073_CR32","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.3390\/ijms20246249","volume":"20","author":"M Correia de Sousa","year":"2019","unstructured":"Correia de Sousa M, Gjorgjieva M, Dolicka D, Sobolewski C, Foti M (2019) Deciphering mirnas\u2019 action through MiRNA editing. Int J Mol Sci 20(24):6249. https:\/\/doi.org\/10.3390\/ijms20246249. Published 2019 Dec 11","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11073_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1021\/jf303972f","volume":"61","author":"A Castell-Auv\u00ed","year":"2013","unstructured":"Castell-Auv\u00ed A, Ced\u00f3 L, Movassat J (2013) Procyanidins modulate MicroRNA expression in pancreatic islets. J Agric Food Chem 61(2):355\u2013363. https:\/\/doi.org\/10.1021\/jf303972f","journal-title":"J Agric Food Chem"},{"issue":"4","key":"11073_CR34","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1002\/jcp.26510","volume":"234","author":"R Ranjbar","year":"2019","unstructured":"Ranjbar R, Karimian A, Aghaie Fard A et al (2019) The importance of miRNAs and epigenetics in acute lymphoblastic leukemia prognosis. J Cell Physiol 234(4):3216\u20133230. https:\/\/doi.org\/10.1002\/jcp.26510","journal-title":"J Cell Physiol"},{"issue":"4","key":"11073_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jpha.2019.05.004","volume":"9","author":"J Ye","year":"2019","unstructured":"Ye J, Xu M, Tian X, Cai S, Zeng S (2019) Research advances in the detection of MiRNA. J Pharm Anal 9(4):217\u2013226. https:\/\/doi.org\/10.1016\/j.jpha.2019.05.004","journal-title":"J Pharm Anal"},{"issue":"21","key":"11073_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111887","volume":"22","author":"S Pietrasik","year":"2021","unstructured":"Pietrasik S, Dziedzic A, Miller E, Starosta M, Saluk-Bijak J (2021) Circulating miRNAs as potential biomarkers distinguishing relapsing-remitting from secondary progressive multiple sclerosis. A review. Int J Mol Sci 22(21):11887. https:\/\/doi.org\/10.3390\/ijms222111887","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11073_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042255","volume":"25","author":"GL Cipriano","year":"2024","unstructured":"Cipriano GL, Schepici G, Mazzon E, Anchesi I (2024) Multiple sclerosis: roles of miRNA, lcnRNA, and circRNA and their implications in cellular pathways. Int J Mol Sci 25(4):2255. https:\/\/doi.org\/10.3390\/ijms25042255","journal-title":"Int J Mol Sci"},{"key":"11073_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2019.04.002","volume":"101","author":"E Piket","year":"2019","unstructured":"Piket E, Zheleznyakova GY, Kular L, Jagodic M (2019) Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: a comprehensive overview. J Autoimmun 101:17\u201325. https:\/\/doi.org\/10.1016\/j.jaut.2019.04.002","journal-title":"J Autoimmun"},{"issue":"1","key":"11073_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrc2293","volume":"8","author":"DC Altieri","year":"2008","unstructured":"Altieri DC (2008) Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8(1):61\u201370. https:\/\/doi.org\/10.1038\/nrc2293","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"11073_CR40","doi-asserted-by":"publisher","first-page":"512","DOI":"10.4049\/jimmunol.1000928","volume":"185","author":"J Correale","year":"2010","unstructured":"Correale J, Fiol M, Gilmore W (2010) The risk of relapses in multiple sclerosis during systemic infections. J Immunol 185(2):512\u2013519. https:\/\/doi.org\/10.4049\/jimmunol.1000928","journal-title":"J Immunol"},{"key":"11073_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fimmu.2011.00059","volume":"2","author":"K Pahan","year":"2011","unstructured":"Pahan K (2011) Immunomodulation of experimental allergic encephalomyelitis by cinnamon metabolite sodium benzoate. Front Immunol 2:59. 10.3389\/ fimmu.2011.00059","journal-title":"Front Immunol"},{"issue":"3","key":"11073_CR42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.immuni.2010.03.012","volume":"32","author":"J Zhu","year":"2010","unstructured":"Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4\u2009+\u2009T cell populations. Immunity 32(3):305\u2013312. 10.1016\/j. immuni.2010.03.002","journal-title":"Immunity"},{"key":"11073_CR43","unstructured":"Dombrowski Y, O\u2019Hagan T, Dittmer M, Penalva R, Mayoral SR, Bankhead P et al (2017) Regulatory T cells promote myelin regeneration in the CNS. Cell. ;170(1):191. doi: 10.1016\/ j. cell.2017.06.021"},{"issue":"1","key":"11073_CR44","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1038\/41467-020-19531-0","volume":"11","author":"S Jiang","year":"2020","unstructured":"Jiang S, Li C, McRae G, Lykken E, Sevilla J, Liu V et al (2020) MiR-3622b-5p targets SOCS1 to enhance JAK\/ STAT signaling in multiple sclerosis. Nat Commun 11(1):5697. https:\/\/doi.org\/10.1038\/41467-020-19531-0","journal-title":"Nat Commun"},{"issue":"8 Suppl","key":"11073_CR45","doi-asserted-by":"publisher","first-page":"LB","DOI":"10.1158\/1538-7445.AM2013-LB-318","volume":"73","author":"M Furuta","year":"2013","unstructured":"Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J (2013) miR-203a suppresses cell proliferation by targeting PTEN in hepatocellular carcinoma. Cancer Res 73(8 Suppl):LB\u2013318. https:\/\/doi.org\/10.1158\/1538-7445.AM2013-LB-318","journal-title":"Cancer Res"},{"key":"11073_CR46","unstructured":"Mayo L, Quintana FJ, Weiner HL (2016) The innate immune system in demyelinating disease. Neuron. ;92(2):437-9. 10.1016\/ j. neuron.2016.10.020"},{"issue":"4","key":"11073_CR47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/00401-020-02193-z","volume":"140","author":"A Junker","year":"2020","unstructured":"Junker A, Hohlfeld R, Meinl E (2020) The emerging role of MicroRNAs in multiple sclerosis. Acta Neuropathol 140(4):401\u2013425. https:\/\/doi.org\/10.1007\/00401-020-02193-z","journal-title":"Acta Neuropathol"},{"issue":"4","key":"11073_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrn.2018.9","volume":"19","author":"AM Krichevsky","year":"2018","unstructured":"Krichevsky AM (2018) MicroRNA profiling: from dark matter to white matter, or identifying new players in neurobiology. Nat Rev Neurosci 19(4):197\u2013214. https:\/\/doi.org\/10.1038\/nrn.2018.9","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"11073_CR49","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.23880","volume":"73","author":"R Gandhi","year":"2013","unstructured":"Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS et al (2013) Circulating micrornas as biomarkers for disease staging in multiple sclerosis. Ann Neurol 73(6):729\u2013740. https:\/\/doi.org\/10.1002\/ana.23880","journal-title":"Ann Neurol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11073-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11073-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11073-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:05:08Z","timestamp":1766898308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11073-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11073"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11073-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval was granted by the Human Research Ethics Committee of Kerman University of Medical Sciences (IR.KMU.REC.1402.085).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Considerations"}},{"value":"Written informed consent obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"1002"}}